Artelo Biosciences, Inc. (ARTL)
7.68
-0.16
(-2.04%)
USD |
NASDAQ |
Apr 02, 10:43
Artelo Biosciences Research and Development Expense (TTM) : 5.423M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| GlucoTrack, Inc. | 9.813M |
| Ovid Therapeutics, Inc. | 25.38M |
| Gossamer Bio, Inc. | 174.07M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |